Urinary and genital infections: what is new?


Accueil Synopsis programme Test CME
Urinary and genital infections: what is new? 09 July 2021 2. Bacterial infection & disease, 1-hour Oral Session • S59 • 14:15 > 15:15 • Urinary and genital infections: what is new? • 2. Bacterial infection 14:15 • 260 • Triple site sexually transmitted infection (STI) testing as a crucial component of surveillance for men who have sex with men (MSM): a prospective cohort study > D. D.Roy ZUCKER (Tel Aviv) 14:25 • 723 • Treatment patterns among females with uncomplicated urinary tract infections pre- and post-issue of a Food and Drug Administration warning for fluoroquinolone-associated serious adverse events > M. Madison T. PREIB (Ann Arbor (Michigan)) 14:35 • 3938 • Efficacy of ertapenem for the treatment of non-severe bacteraemic urinary tract infections due to ESBL-producing Enterobacterales<em> </em>in kidney transplant > S. Salvador Ignacio PÉREZ-GALERA (Seville) 14:45 • 3798 • Temocillin versus cefotaxime in adults with febrile urinary tract infection: a randomised multicentre clinical trial on effect and collateral damage on intestinal microbiota > C. Charlotta EDLUND (Solna) 14:55 • 2420 • Repurposing drugs for syphilis: evaluation of linezolid for syphilis therapy > M. Maria UBALS (Badalona) 15:05 • INT1 • Q&A/Discussion